BSEM BioStem Technologies Inc.
BioStem Technologies Inc. (BSEM) is expected to report earnings on November 11, 2026, after the market close. The consensus earnings estimate is a loss of $0.46 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +39.6% since its last earnings release on August 12, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About BioStem Technologies Inc.
ioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture and commercialization of allografts for regenerative therapies.
Sector
Healthcare
Industry
Biotechnology